UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Optimal design of a population pharmacodynamic experiment for ivabradine

Pharmaceutical research, 2001, Vol.18 (1), p.83-89

2001

Volltextzugriff (PDF)

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.583-587

2003

Volltextzugriff (PDF)

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Journal of pharmacokinetics and pharmacodynamics, 2001-06, Vol.28 (3), p.299-319

2001

Volltextzugriff (PDF)

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Journal of pharmacokinetics and pharmacodynamics, 2004-12, Vol.31 (6), p.419-440

2004

Volltextzugriff (PDF)

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Journal of pharmacokinetics and biopharmaceutics, 1998-12, Vol.26 (6), p.689-716

1998

Volltextzugriff (PDF)

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

Journal of pharmacokinetics and biopharmaceutics, 1999-04, Vol.27 (2), p.213-230

1999

Volltextzugriff (PDF)

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.161-183

2005

Volltextzugriff (PDF)

Optimization of individual and population designs using Splus

Journal of pharmacokinetics and pharmacodynamics, 2003-12, Vol.30 (6), p.417-443

2003

Volltextzugriff (PDF)

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Journal of pharmacokinetics and biopharmaceutics, 1999-02, Vol.27 (1), p.85-101

1999

Volltextzugriff (PDF)

Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method

Journal of pharmacokinetics and biopharmaceutics, 1998-04, Vol.26 (2), p.133-161

1998

Volltextzugriff (PDF)

Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses : Noncompartmental approach and compartmental modeling

Journal of Pharmacokinetics and Biopharmaceutics, 1997-04, Vol.25 (2), p.125-147

1997

Volltextzugriff (PDF)

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

Therapeutic innovation & regulatory science, 1995, Vol.29 (3), p.997-1019

1995

Volltextzugriff (PDF)

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy

Clinical pharmacokinetics, 2005-01, Vol.44 (12), p.1267-1278

2005

Volltextzugriff (PDF)

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

European journal of clinical pharmacology, 2009-07, Vol.65 (7), p.667-678

2009

Volltextzugriff (PDF)

Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2

Cancer chemotherapy and pharmacology, 2005, Vol.55 (1), p.61-71

2005

Volltextzugriff (PDF)

The use of population pharmacokinetics in drug development

Clinical pharmacokinetics, 1996-02, Vol.30 (2), p.81-93

1996

Volltextzugriff (PDF)

Clinical pharmacokinetics of zidovudine : inter and intraindividual variability and relationship to long term efficacy and toxicity

European journal of clinical pharmacology, 1993-12, Vol.45 (5), p.397-407

1993

Volltextzugriff (PDF)

Bayesian design criteria : computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model

Journal of pharmacokinetics and biopharmaceutics, 1995-02, Vol.23 (1), p.101-125

1995

Volltextzugriff (PDF)

New strategies in drug development and clinical evaluation : the population approach : commentary on an action for co-operative research

European journal of clinical pharmacology, 1993-09, Vol.45 (2), p.93-94

1993

Volltextzugriff (PDF)

A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

Cancer chemotherapy and pharmacology, 1991-01, Vol.28 (2), p.123-129

1991

Volltextzugriff (PDF)

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

Journal of pharmacokinetics and biopharmaceutics, 1988-06, Vol.16 (3), p.311-327

1988

Volltextzugriff (PDF)

Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

European journal of clinical pharmacology, 2007-11, Vol.63 (11), p.1019-1029

2007

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink (Online service)

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(22)
Pharmacology. Drug Treatments
(21)
Life Sciences & Biomedicine
(19)
Pharmacology & Pharmacy
(19)
Science & Technology
(19)
Humans
(18)
Pharmacokinetics
(11)
Models, Biological
(9)
General Pharmacology
(7)
Adult
(6)
Female
(6)
Male
(6)
Pharmacokinetics. Pharmacogenetics. Drug-Receptor Interactions
(6)
Computer Simulation
(5)
Middle Aged
(5)
Models, Statistical
(5)
Population Pharmacokinetics
(5)
Administration, Oral
(4)
Algorithms
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimal design of a population pharmacodynamic experiment for ivabradine

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis : An application to basiliximab in renal transplantation

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Optimization of individual and population designs using Splus

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood method

Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses : Noncompartmental approach and compartmental modeling

Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2

The use of population pharmacokinetics in drug development

Clinical pharmacokinetics of zidovudine : inter and intraindividual variability and relationship to long term efficacy and toxicity

Bayesian design criteria : computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model

New strategies in drug development and clinical evaluation : the population approach : commentary on an action for co-operative research

A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients

Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine

Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART

Aktive Filter

Suchergebnisse filtern